Mogens Hørder
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Alkaline Phosphatase Research Studies
-
- Acute Myocardial Infarction Research
- Cardiac electrophysiology and arrhythmias
Papers in
-
- Porphyrin Metabolism and Disorders 11
- Heme Oxygenase-1 and Carbon Monoxide 9
- Surgery 29
- Lipoproteins and Cardiovascular Health 14
- Co-authors
- Nils Tryding (6 shared papers)J. Waldenström (5 shared papers)L Theodorsen (6 shared papers)J H Strømme (5 shared papers)E. Pitkänen (3 shared papers)R Tenhunen (2 shared papers)Per Hyltoft Petersen (31 shared papers)Robert Rej (2 shared papers)
- Journals
- Scandinavian Journal of Clinical and Laboratory Investigation (43 papers)Clinical Chemistry (13 papers)Clinica Chimica Acta (9 papers)Atherosclerosis (5 papers)Acta Haematologica (5 papers)
- Partner nations
- DenmarkUnited KingdomNorway
In The Last Decade
Mogens Hørder
175 papers receiving 5.1k citations
Mogens Hørder's Hit Papers
Peers
Comparison fields: 5 of 165
- Endocrinology, Diabetes and Metabolism 938
- Cardiology and Cardiovascular Medicine 951
- Pharmacology 319
- Clinical Biochemistry 228
- Statistics, Probability and Uncertainty 200
Countries citing papers authored by Mogens Hørder
This map shows the geographic impact of Mogens Hørder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mogens Hørder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mogens Hørder more than expected).
Fields of papers citing papers by Mogens Hørder
This network shows the impact of papers produced by Mogens Hørder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mogens Hørder. The network helps show where Mogens Hørder may publish in the future.
Co-authors
The 25 scholars most cited alongside Mogens Hørder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 180 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recommended Methods for the Determination of Four Enzymes in Blood Hit paper breakdown → | 1974 | 780 |
| 2 | Recommended Methods for the Determination of Four Enzymes in Blood Hit paper breakdown → | 1974 | 727 |
| 3 | International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC method for aspartate aminotransferase (L-aspartate: 2-oxoglutarate aminotransferase, EC 2.6.1.1). | 1986 | 343 |
| 4 | 2001 | 232 | |
| 5 | 1995 | 200 | |
| 6 | 1990 | 191 | |
| 7 | 1976 | 178 | |
| 8 | 1993 | 149 | |
| 9 | 1979 | 146 | |
| 10 | 1988 | 130 | |
| 11 | 1992 | 111 | |
| 12 | 1994 | 90 | |
| 13 | 2005 | 87 | |
| 14 | International Federation of Clinical Chemistry, Scientific Division Committee on Enzymes: approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 7. IFCC method for creatine kinase (ATP: creatine N-phosphotransferase, EC 2.7.3.2). | 1991 | 63 |
| 15 | 2008 | 62 | |
| 16 | Approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC method for aspartate aminotransferase (L-aspartate: 2-oxoglutarate aminotransferase, EC 2.6.1.1) | 1986 | 62 |
| 17 | 1998 | 59 | |
| 18 | 1980 | 58 | |
| 19 | 1982 | 54 | |
| 20 | International federation of clinical chemistry. Scientific committee. Expert panel on enzymes. IFCC document stage 2, draft 1; 1979-11-19 with a view to an IFCC recommendation. IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase. | 1980 | 53 |
About Mogens Hørder
Mogens Hørder is a scholar working on Molecular Biology, Surgery, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology, having authored 180 papers that have together received 5.5k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers), Lipoproteins and Cardiovascular Health (14 papers), Clinical Laboratory Practices and Quality Control (12 papers), Porphyrin Metabolism and Disorders (11 papers), Cardiac Imaging and Diagnostics (10 papers), Folate and B Vitamins Research (10 papers), Diabetes Management and Research (9 papers) and Heme Oxygenase-1 and Carbon Monoxide (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (938 citations), Cardiology and Cardiovascular Medicine (951 citations), Pharmacology (319 citations), Clinical Biochemistry (228 citations) and Statistics, Probability and Uncertainty (200 citations). Mogens Hørder has collaborated with scholars based in Denmark, United Kingdom and Norway. Frequent co-authors include Nils Tryding, J. Waldenström, L Theodorsen, J H Strømme, E. Pitkänen, R Tenhunen, Per Hyltoft Petersen, Robert Rej, Bergmeyer Hu and Henrik Nissen. Their work appears in journals such as Scandinavian Journal of Clinical and Laboratory Investigation, Clinical Chemistry, Clinica Chimica Acta, Atherosclerosis and Acta Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.